Litigation Details for CHIESI USA, INC. v. GLAND PHARMA LTD. (D.N.J. 2019)
✉ Email this page to a colleague
CHIESI USA, INC. v. GLAND PHARMA LTD. (D.N.J. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-09-30 |
| Court | District Court, D. New Jersey | Date Terminated | 2022-06-29 |
| Cause | 35:271 Patent Infringement | Assigned To | Madeline Cox Arleo |
| Jury Demand | None | Referred To | Michael A. Hammer |
| Patents | 10,039,780; 6,130,208; 9,295,687; 9,427,448; 9,439,921; 9,700,575; 9,925,265 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in CHIESI USA, INC. v. GLAND PHARMA LTD.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for CHIESI USA, INC. v. GLAND PHARMA LTD. (D.N.J. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-09-30 | 1 | Complaint | eight (8) patents as covering Chiesi’s Kengreal®: (1) U.S. Patent No. 10,039,780 (“the ’780 patent”); (2)…’780 patent, the ’208 patent, the ’502 patent, the ’448 patent, the ’921 patent, the ’575 patent, or …the ’502 patent, the ’448 patent, the ’921 patent, the ’575 patent, or the ’265 patent. 31. …the ’502 patent, the ’448 patent, the ’921 patent, the ’575 patent, or the ’265 patent. 32. …before the patent expiration for the ’780 patent, the ’208 patent, the ’502 patent, the ’448 patent, the ’ | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
